XBP1 and acute lymphoblastic leukemia: In addition, treated cells reduced expression levels of Il7r, indicating pharmacological inhibition of IRE1α negatively impacting IL‐7R signalling through the loss of XBP1 splicing in pre‐B ALL cells (Figure 3A).